- ►diabetesjournals.org M Alssema, JM Dekker, G Nijpels, CDA … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Fasting and post–75-g glucose-load (2-h)
glucose, insulin, and proinsulin values were determined in duplicate on separate
days in 277 participants with normal glucose metabolism, 208 participants ... Cited by 4 - Related articles - All 2 versions
- Free from Publisher M Alssema, JM Dekker, G Nijpels, CDA … - Diabetes care, 2005 - cat.inist.fr OBJECTIVE- High proinsulin concentration may be a better predictor for
cardiovascular disease(CVD) mortality than insulin concentration. Previous
observations may have been confounded by glucose tolerance status or lack ... Cited by 16 - Related articles - All 3 versions
- ►adisonline.com [PDF] GTC Ko, CC Tsang, CW Ng, HPS Wai, ECY … - Clinical Drug Investigation, 2001 - ingentaconnect.com Gary TC Ko, 1 Chiu-Chi Tsang, 1 Chi-Wai Ng, 1 Hendena PS Wai 2 and Eva CY Kan 1 ... 1 Department of Medicine, Alice Ho Miu Ling Nethersole Hospital, Hong Kong
2 Department of Clinical Oncology, Pamela Youde Nethersole Eastern ... Cited by 1 - Related articles - BL Direct - All 3 versions
[CITATION] The Use of Acarbose as Combination Therapy for Type 2 Diabetics
M Yamamoto, M Otsuki - Metabolism, 2006 - Elsevier Oral administration of α-glucosidase inhibitor reduces postprandial serum
glucose and insulin concentrations; thus, α-glucosidase inhibitor is used for
the treatment of diabetes mellitus worldwide. In our study, we have ... Cited by 3 - Related articles - All 14 versions
